Comparison of oral and intravenous Alfacalcidol in chronic hemodialysis patients

BACKGROUND: Activated vitamin D is the mainstay of treatment for secondary hyperparathyroidism (SHPT) in chronic hemodialysis patients. However, the optimal route of administration is still debated. The aim of our study was to compare efficacy of oral vs intravenous (IV) administration of alfacalcid...

Descripción completa

Detalles Bibliográficos
Autores principales: Lessard, Myriam, Ouimet, Denis, Leblanc, Martine, Nadeau-Fredette, Annie-Claire, Bell, Robert, Lafrance, Jean-Philippe, Pichette, Vincent, Vallée, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915223/
https://www.ncbi.nlm.nih.gov/pubmed/24495277
http://dx.doi.org/10.1186/1471-2369-15-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915223/
https://www.ncbi.nlm.nih.gov/pubmed/24495277
http://dx.doi.org/10.1186/1471-2369-15-27

Ejemplares similares